Randomized Trial of Milrinone Versus Placebo for Prevention of Low Systemic Blood Flow in Very Preterm Infants

Journal of Pediatrics

Volumn 154, Issue 2, 2009, Pages 189-195

  Paradisis, Mary ^a,b,c   Evans, Nick ^b,c   Kluckow, Martin ^a,c   Osborn, David ^b,c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE;

ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SUPERIOR CAVA VEIN; SYSTEMIC CIRCULATION; ULTRASOUND;

BLOOD PRESSURE; CARDIAC OUTPUT, LOW; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MILRINONE; MONITORING, PHYSIOLOGIC; VASODILATOR AGENTS; VENA CAVA, SUPERIOR;

EID: 58149528347     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.07.059     Document Type: Article

References (33)

1. Wilson-Costello D., Friedman H., Minich N., Siner B., Taylor G., Schluchter M., et al. Improved neurodevelopmental outcomes for extremely low birth weight infants in 2000-2002. Pediatr 119 (2007) 37-45
2. Doyle L.W., and Victorian Infant Collaborative Study Group. Neonatal intensive care at borderline viability-is it worth it?. Early Human Dev 80 (2004) 103-113
3. Lou H.C., Skov H., and Pedersen H. Low cerebral blood flow: a risk factor in the neonate. J Pediatr 95 (1979) 606-609
4. Meek J.H., Tyszczuk L., Elwell C.E., and Wyatt J.S. Low cerebral blood flow is a risk factor for severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed 81 (1999) F15-F18
5. Kluckow M., and Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 82 (2000) 188-194
6. Osborn D.A., Evans N., and Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatr 112 (2003) 33-39
7. Kluckow M., and Evans N. Superior vena cava flow in preterm infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed 82 (2000) 182-187
8. Kluckow M., and Evans N. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation. J Pediatr 129 (1996) 506-512
9. Osborn D.A., Evans N., and Kluckow M. Left ventricular contractility in extremely premature infants in the first day and response to inotropes. Pediatr Res 61 (2007) 335-340
10. Hunt R.W., Evans N., Rieger I., and Kluckow M. Low superior vena cava flow and neurodevelopment at 3 years in very preterm infants. J Pediatr 145 (2004) 588-592
11. Osborn D.A., Evans N., Kluckow M., Bowen J.R., and Rieger I. Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants. Pediatr 120 (2007) 372-380
12. Osborn D., Evans N., and Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 140 (2002) 183-191
13. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75 (1995) 725-748
14. Chang A.C., Atz A.M., Wernovsky G., Burke R.P., and Wessel D.L. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 23 (1995) 1907-1914
15. Bailey J.M., Hoffman T.M., Wessel D.L., Nelson D.P., Atz A.M., Chang A.C., et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodynam 31 (2004) 43-59
16. Duggal B., Pratap U., Slavik Z., Kaplanova J., and Macrae D. Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect?. Pediatr Cardiol 26 (2005) 642-645
17. Ramamoorthy C., Anderson G.D., Williams G.D., and Lynn A.M. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 86 (1998) 283-289
18. Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J., Nelson D.P., Chang A.C., et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107 (2003) 996-1002
19. Barton P., Garcia J., Kouatli A., Kitchen L., Zorka A., Lindsay C., et al. Hemodynamic effects of intravenous milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 109 (1996) 1302-1312
20. Lindsay C.A., Barton P., Lawless S., Kitchen L., Zorka A., Garcia J., et al. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 132 (1998) 329-334
21. Paradisis M., Evans N., Kluckow M., Osborn D., and McLachlan A.J. Pilot study of milrinone for low systemic blood flow in very preterm infants. J Pediatr 148 (2006) 306-313
22. Paradisis M., Jiang X.M., McLachlan A.J., Evans N., Kluckow M., and Osborn D. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch Dis Child Fetal Neonatal Ed 92 (2007) F204-F209
23. Papile L.A., Burstein J., Burstein R., and Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 92 (1978) 529-534
24. Evans N., and Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 75 (1996) F183-F186
25. Evans N., Kluckow M., Simmons M., and Osborn D. Which to measure, systemic or organ blood flow?. Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 87 (2002) F181-F184
26. Ogawa S., Nakanishi T., Kamata K., and Takao A. Effect of milrinone on myocardial mechanical function and cyclic AMP content in the fetal rabbit. Pediatr Res 22 (1987) 282-285
27. Oquist N.L., Strada S.J., and Artman M. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium. Pediatr Res 31 (1992) 300-304
28. Hoffman T.M., Wessel D.L., Chang A.C., Kulik T.L., Atz A.M., Nelson D.P., et al. Milrinone usage in the neonate following congenital cardiac surgery: experience from the PRIMACORP Trial (2007), Society for Pediatric Research (Abstract 7360.6)
29. Osborn D.A., Evans N., and Kluckow M. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 88 (2003) F477-F482
30. Momma K., Toyoshima K., Imamura S., and Nakanishi T. In vivo dilation of fetal and neonatal ductus arteriosus by inhibition of phosphodiesterase-5 in rats. Pediatr Res 58 (2005) 42-45
31. Toyoshima K., Momma K., Imamura S., and Nakanishi T. In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats. Biol Neonate 89 (2006) 251-256
32. Osborn D.A., and Evans N. Early volume expansion for prevention of morbidity and mortality in very preterm infants [update of Cochrane Database Systematic Reviews] (2001) (4):CD002055
33. Al Aweel I., Pursley D.M., Rubin L.P., Shah B., Weisberger S., and Richardson D.K. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 21 (2001) 272-278